Inventor · disambiguated record
Michael Bottger
Also filed as: BOTTGER MICHAEL · BÖTTGER MICHAEL
2 granted patents·9 pending applications·1 citations·filing 2012–2015
28Inventor score
Files withBAYER HEALTHCARE LLC4Bayer Pharma AG2HEINRICH KELDENICH PETRA2BOTTGER MICHAEL1BÖTTGER MICHAEL1
Top patents by PatentIndex Score
11 records- 0161US9040691B2Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitorsKLAR JÜRGEN·Filed 2012·Granted May 26, 2015·1 cites·8 claims
- 0247US2014179745A1Topical ophthalmological pharmaceutical composition containing regorafenibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 0346US2015328145A1Topical ophthalmological pharmaceutical composition containing regorafenibHEINRICH KELDENICH PETRA·Filed 2013·Application pending·0 cites
- 0445US2015164790A1Topical Ophthalmological Pharmaceutical Composition containing AxitinibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 0543US2014235678A1Topical Ophthalmological Pharmaceutical Composition containing SorafenibBÖTTGER MICHAEL·Filed 2012·Application pending·0 cites
- 0643US2016009776A1Pdgfrbeta-fc fusion proteins and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 0739US2015174096A1Topical ophthalmological pharmaceutical composition containing sunitinibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 0837US2015141448A1Topical Ophthalmological Pharmaceutical Composition containing PazopanibBAYER HEALTHCARE LLC·Filed 2013·Application pending·0 cites
- 0937US2015165028A1Topical ophthalmological pharmaceutical composition containing cediranibHEINRICH KELDENICH PETRA·Filed 2013·Application pending·0 cites
- 1035US2014296301A1Topical ophthalmological pharmaceutical composition containing regoragenibBOTTGER MICHAEL·Filed 2012·Application pending·0 cites
- 1131US10047096B2Substituted pyridobenzodiazepinone-derivatives and use thereofBayer Pharma AG·Filed 2015·Granted Aug 14, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Michael Bottger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →